OpenBilldrug price receipt

NADAC week of 2026-10-14

CLOPIDOGREL 75 MG TABLET

For 30 tablets

Pharmacies pay

$1.42 filed

30 × $0.04719 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$5.30 filed

30 × $0.1766 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.7× estimated

Medicare paid 3.7× what pharmacies pay.

Part D averages every strength and form sold under “Clopidogrel” / “Clopidogrel Bisulfate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.63 estimated

$1.42 + $0.21 (15%) + $5.00 fee per fill = $6.63

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CLOPIDOGREL 75 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “clopidogrel bisulfate” and “clopidogrel”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Limited and NorthStar RxLLC.

FDA’s Established Pharmacologic Class for it is P2Y12 Platelet Inhibitor.

The NADAC file of 2026-10-14 prices it under 41 NDCs (National Drug Codes); the FDA directory lists 38 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.42 for 30 tablets (30 × $0.04719 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 14 labelers

LabelerNDCsPharmacies pay per unit
NorthStar RxLLC6$0.04719 per EA filed
Dr.Reddy's Laboratories Inc5$0.04719 per EA filed
Novadoz Pharmaceuticals LLC4$0.04719 per EA filed
ScieGen Pharmaceuticals Inc4$0.04719 per EA filed
Aurobindo Pharma Limited3$0.04719 per EA filed
Torrent Pharmaceuticals Limited3$0.04719 per EA filed
Apotex Corp.2$0.04719 per EA filed
Ascend Laboratories, LLC2$0.04719 per EA filed
Macleods Pharmaceuticals Limited2$0.04719 per EA filed
Quallent Pharmaceuticals Health LLC2$0.04719 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.04719 per EA filed
American Health Packaging1$0.04719 per EA filed
Legacy Pharmaceutical Packaging, LLC1$0.04719 per EA filed
Westminster Pharmaceuticals, LLC1$0.04719 per EA filed
Not listed as a package in the FDA directory3$0.04719 per EA filed
All 41 NDCs, with labeler and price
  • 00093-7314-05 · Teva Pharmaceuticals USA, Inc. · $0.04719 per EA · eff. 2026-09-23 filed
  • 00093-7314-56 · Teva Pharmaceuticals USA, Inc. · $0.04719 per EA · eff. 2026-09-23 filed
  • 13668-0141-05 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 13668-0141-30 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 13668-0141-90 · Torrent Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-01 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-02 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-03 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-04 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-10 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 16714-0052-11 · NorthStar RxLLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 33342-0060-10 · Macleods Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 33342-0060-15 · Macleods Pharmaceuticals Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 43598-0121-05 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 43598-0121-30 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 43598-0121-90 · Dr.Reddy's Laboratories Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 50228-0124-05 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 50228-0124-10 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 50228-0124-30 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 50228-0124-90 · ScieGen Pharmaceuticals Inc · $0.04719 per EA · eff. 2026-09-23 filed
  • 55111-0196-05 · Dr.Reddy's Laboratories Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 55111-0196-90 · Dr.Reddy's Laboratories Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 60505-0253-02 · Apotex Corp. · $0.04719 per EA · eff. 2026-09-23 filed
  • 60505-0253-03 · Apotex Corp. · $0.04719 per EA · eff. 2026-09-23 filed
  • 65862-0357-05 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 65862-0357-30 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 65862-0357-61 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
  • 65862-0357-90 · Aurobindo Pharma Limited · $0.04719 per EA · eff. 2026-09-23 filed
  • 67877-0276-05 · Ascend Laboratories, LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 67877-0276-90 · Ascend Laboratories, LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 68084-0536-01 · American Health Packaging · $0.04719 per EA · eff. 2026-09-23 filed
  • 68084-0536-11 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
  • 68645-0590-90 · Legacy Pharmaceutical Packaging, LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 69367-0200-05 · Westminster Pharmaceuticals, LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 72205-0199-01 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 72205-0199-05 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 72205-0199-30 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 72205-0199-90 · Novadoz Pharmaceuticals LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 82009-0021-05 · Quallent Pharmaceuticals Health LLC · $0.04719 per EA · eff. 2026-09-23 filed
  • 82009-0021-90 · not listed as a package in the FDA directory · $0.04719 per EA · eff. 2026-09-23 filed
  • 82009-0182-05 · Quallent Pharmaceuticals Health LLC · $0.04719 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with CLOPIDOGREL 75 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
CLOPIDOGREL 75 MG TABLET this page
generic · tablet, film coated / tablet
$0.04719 per EA filed
eff. 2026-09-23
$0.1766 per EA filed
Part D 2024 average
CLOPIDOGREL 300 MG TABLET
generic · tablet, film coated
$5.29107 per EA filed
eff. 2026-09-23
$0.1766 per EA filed
Part D 2024 average
PLAVIX 75 MG TABLET
brand · tablet, film coated
$8.22931 per EA filed
eff. 2026-09-23
$7.86971 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 41 NDCs’ NADAC prices is $0.04719 per EA filed.

Of the 8 other products in FDA’s P2Y12 Platelet Inhibitor class priced per EA, 8 have a higher middle NADAC price and 0 a lower one. The one in the middle is TICAGRELOR 60 MG TABLET, at $0.28214 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $5.30 for 30 tablets, at an average of $0.1766 per EA in 2024 (2024-01-01 to 2024-12-31) for “Clopidogrel” and “Clopidogrel Bisulfate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 13,582,037 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CLOPIDOGREL 75 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Clopidogrel / Clopidogrel Bisulfate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.